MBCL-30. SUBGROUP-DIRECTED CLINICAL AND MOLECULAR STRATIFICATION OF DISEASE RISK IN INFANT MEDULLOBLASTOMA

Understanding the specific molecular pathology of infant medulloblastoma (iMB) is urgently required to inform contemporary treatments, risk-stratification and clinical trials. Comprehensive analysis incorporating central clinical/ pathological review and molecular subgroup, copy number aberration an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Hicks, Debbie, Rafiee, Gholamreza, Schwalbe, Edward C, Lindsey, Janet C, Hill, Rebecca M, Smith, Amanda, Crosier, Stephen, Joshi, Abhijit, Robson, Keith, Wharton, Stephen, Jacques, Thomas, Williamson, Daniel, Bailey, Simon, Clifford, Steven C
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.426
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg